CGNX Stock Falls -14% With A 8-day Losing Spree On Insider Selling
Cognex (CGNX) – a machine vision solution for automated manufacturing inspection and guidance – hit a 8-day losing streak, with cumulative losses over this period amounting to -14%. The company’s market cap has crashed by about $1.3 Bil over the last 8 days and currently stands at $8.3 Bil.
The stock has YTD (year-to-date) return of 37.6% compared to -1.5% for S&P 500. This calls for a re-evaluation of the stock’s valuation to find out whether this is an opportunity or a trap.
What Triggered The Slide?
[1] Insider Stock Sales
- Stress Testing ONDS: Historical Drawdowns and Macro Risks
- The Bear Case: How NN Behaves During Market Shocks
- Stress Testing WMT: Historical Drawdowns and Macro Risks
- The Bear Case: How IBM Behaves During Market Shocks
- The Bear Case: How SATS Behaves During Market Shocks
- 4 Catalysts to Monitor Over In The Next 2 Quarters For BRK-B Stock
- Director sold 15,600 shares on March 2
- SEC filing on March 3 for a 44,000 share director trade
- Impact: Negative investor sentiment, Increased selling pressure
[2] Weakening Automotive Demand Outlook
- Automotive demand continues to weaken year-over-year
- EBITDA margin guidance suggests minimal growth
- Impact: Concerns over a key sales sector, Profit-taking after recent stock price gains
Opportunity or Trap?
Below is our take on valuation.
There are only a couple of things to fear in CGNX stock given its overall Moderate operating performance and financial condition. But keeping in mind its Very High valuation, we think that the stock is Unattractive (For details, see Buy or Sell CGNX).
But here is the real interesting point.
You are reading about this -14% move after it happened. The market has already priced in the news. To avoid the next loser before the headlines, you need predictive signals, not notifications. Our High Quality Portfolio has a risk model designed to reduce exposure to losers.
Returns vs S&P 500
The following table summarizes the return for CGNX stock vs. the S&P 500 index over different periods, including the current streak:
| Return Period | CGNX | S&P 500 |
|---|---|---|
| 1D | -3.5% | -1.3% |
| 8D (Current Streak) | -14.6% | -2.2% |
| 1M (21D) | 21.6% | -2.1% |
| 3M (63D) | 31.4% | -1.6% |
| YTD 2026 | 37.6% | -1.5% |
| 2025 | 1.2% | 16.4% |
| 2024 | -13.4% | 23.3% |
| 2023 | -10.8% | 24.2% |
Take a look at what history tells you about whether past dips like this have been buying opportunities or traps: CGNX Dip Buyer Analysis.
Gains and Losses Streaks: S&P 500 Constituents
There are currently 29 S&P constituents with 3 days or more of consecutive gains and 121 constituents with 3 days or more of consecutive losses.
| Consecutive Days | # of Gainers | # of Losers |
|---|---|---|
| 3D | 7 | 17 |
| 4D | 9 | 46 |
| 5D | 9 | 32 |
| 6D | 1 | 18 |
| 7D or more | 3 | 8 |
| Total >=3 D | 29 | 121 |
Key Financials for Cognex (CGNX)
Last 2 Fiscal Years:
| Metric | FY2024 | FY2025 |
|---|---|---|
| Revenues | $914.5 Mil | $994.4 Mil |
| Operating Income | $115.1 Mil | $162.6 Mil |
| Net Income | $106.2 Mil | $114.4 Mil |
Last 2 Fiscal Quarters:
| Metric | 2025 FQ3 | 2025 FQ4 |
|---|---|---|
| Revenues | $276.9 Mil | $252.3 Mil |
| Operating Income | $57.8 Mil | $35.3 Mil |
| Net Income | $17.7 Mil | $32.7 Mil |
The losing streak CGNX stock is currently on doesn’t inspire much confidence among investors. In contrast, Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 — the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.